Receiving 1g azithromycin as part of mass drug administration (MDA) for the control of trachoma is associated with reduced genital Mycoplasma genitalium prevalence.

Harrison, M; Harding-Esch, EM; Marks, M; Pond, MJ; Butcher, R; Solomon, A; Tan, NK; Nori, AV; Kako, H; Mabey, DC; +1 more... Sadiq, ST; (2017) Receiving 1g azithromycin as part of mass drug administration (MDA) for the control of trachoma is associated with reduced genital Mycoplasma genitalium prevalence. [Conference or Workshop Item] https://doi.org/10.1136/sextrans-2017-053232.61

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/sextrans-2017-053232.61

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar

Google Scholar
Report this Record Edit item (admin only) View this record in elements